Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: A two-edged weapon in chronic fatigue syndrome

Annamaria Pasi, Sara Bozzini, Nicoletta Carlo-Stella, Miryam Martinetti, Stefano Bombardieri, Annalisa De Silvestri, Laura Salvaneschi, Mariaclara Cuccia

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic fatigue syndrome (CFS) is an inflammatory disease of unknown aetiology. Researchers have proposed infectious, neurological and immunological causes of this syndrome. Recently, the xenotropic murine leukemia virus-related virus was detected in 67% of patients with CFS in a US study. This observation is in agreement with one ascertained aspect of the disease: a decreased efficiency in NK cell lytic activity in CFS patients. Here, we analyzed the genomic polymorphism of killer cell immunoglobulin-like receptors (KIRs) and their HLA class I cognate ligands in patients with certified CFS. An excess of KIR3DS1 was found in CFS patients with respect to controls, as well as an increased frequency of the genotype missing KIR2DS5. Forty-four CFS patients and 50 controls also underwent genomic typing for the HLA-ligands. In the patients, a great proportion of KIR3DL1 and KIR3DS1 receptors were found to be missing their HLA-Bw4 Ile80 binding motif. We hypothesize that an excess of KIR3DS1, combined with an excess of ligand-free KIR3DL1 and KIR3DS1 receptors, may hamper the clearance of a pathogen via NK cells, thus favouring the chronicity of the infection.

Original languageEnglish
Pages (from-to)535-540
Number of pages6
JournalMolecular Medicine Reports
Volume4
Issue number3
DOIs
Publication statusPublished - May 2011

Keywords

  • Chronic fatigue syndrome
  • HLA class I ligands
  • Killer cell immunoglobulin-like receptors

ASJC Scopus subject areas

  • Biochemistry
  • Cancer Research
  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Oncology

Fingerprint Dive into the research topics of 'Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: A two-edged weapon in chronic fatigue syndrome'. Together they form a unique fingerprint.

Cite this